vTv Therapeutics Inc. filed its 10-K on Mar 06, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.83 USD | +5.22% | +13.21% | +133.30% |
14/03 | VTv Therapeutics Inc. Announces Board Changes | CI |
13/03 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+133.30% | 65.27M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Auditor Raises 'Going Concern' Doubt